The PBC Biomed team will be exhibiting at the 9th ESTROT Congress this year; taking place in the University of Leeds from 30th May – 1st June. Our team will be available on our stand to provide information on our latest development programmes; or alternatively, attend our dedicated Keynote session to learn more about our […]
PBC Biomed will be exhibiting at the American Academy of Orthopaedic Surgeons (AAOS) in San Diego this year, scheduled to take place from March 10th – 14th. We will be sharing information on our latest development programmes and consultancy services. If you wish to schedule a meeting with one of our representatives, please reach out
Strengthening Partnerships: Mochida Pharmaceuticals Visits Shannon HQ to discuss 2025 Collaborative Projects The Mochida Pharmaceuticals leadership, quality and regulatory teams visited our headquarters in Shannon, Ireland this month, to discuss collaborative development projects for 2025 and beyond. We are pleased to share that the future is bright, with projects planned for trauma, tendon & ligament,
Innovation Lab at University of Leeds Last week the PBC Biomed team held their first innovation lab of the year in the University of Leeds Teaching Hospital. Our Clinical Advisory Board – Dr Hassan Mir, MD, MBA, Dr John Tracy Watson and Dr Thomas A. (Toney) Russell MD and our host Professor Peter Giannoudis, were
Innovation Lab at University of Leeds Read More »
We are proud to announce that our affiliate partner Biomimetic Innovations Limited(BMI), has announced the execution of an exclusive license and distribution agreement with Sanara MedTech Inc. Sanara agreed to invest in BMI with cash for equity at the same time. Sanara, a medical technology company based in Fort Worth, Texas, with attention to developing
This year our team will continue to work with Mochida Pharmaceutical Ltd. to explore further indications for alginate-based technologies, with projects focused on #tendon protection, #cavernous nerve repair and #cartilage treatment on the horizon. The product pipeline is exciting and our vision is clear – to develop #innovative medical technologies to enhance the wellbeing of
Alginate-Based Technologies with Mochida Pharmaceutical Ltd Read More »
Our mission of ‘Enhancing Patient Wellness’ continues to drive us and will be central to all our activities in 2025. Providing clinical solutions in both Human and Veterinary through our newly released products, *ReFeel® Nerve Repair Solution, HANIA Skin Protectant and OssiVet (Bioadhesive) will be key focus areas, while we continue to work with our
Happy New Year from all of us at PBC Biomed Group! Read More »
